Thallous chloride, tl-201 Pregnancy and Breastfeeding Warnings
Thallous chloride, tl-201 Pregnancy Warnings
This drug should not be used during pregnancy unless the benefit outweighs the risk to the fetus.
AU TGA pregnancy category: Not formally assigned to a pregnancy category.
US FDA pregnancy category: C
Adequate reproductive studies have not been conducted in animals. It is unknown whether this drug can cause fetal harm or affect reproduction capacity when administered to a pregnant woman.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Thallous chloride, tl-201 Breastfeeding Warnings
Breastfeeding is not recommended during use of this drug.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: Consideration should be given as to whether the investigation could be reasonably delayed until the mother has ceased breast feeding.
See also
References for pregnancy information
- Cerner Multum, Inc. "Australian Product Information."
- (2022) "Product Information. Thallous Chloride Tl 201 (thallous chloride Tl-201)." GE Healthcare
References for breastfeeding information
- Cerner Multum, Inc. "Australian Product Information."
- (2022) "Product Information. Thallous Chloride Tl 201 (thallous chloride Tl-201)." GE Healthcare
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.